We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 712.00
Bid: 711.90
Ask: 712.00
Change: 7.00 (0.99%)
Spread: 0.10 (0.014%)
Open: 706.50
High: 712.10
Low: 706.00
Prev. Close: 705.00
HSBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement on the BoE 2018 Stress Test Results

28 Nov 2018 17:35

RNS Number : 8237I
HSBC Holdings PLC
28 November 2018
 

 

 

STATEMENT ON THE BANK OF ENGLAND

2018 STRESS TEST RESULTS

 

 

HSBC Holdings plc ('HSBC') notes the publication today of the results of the Bank of England's 2018 concurrent stress test. The Bank of England's results show that, under the hypothetical annual cyclical stress scenario, HSBC's common equity tier 1 ('CET1') capital ratio on an IFRS 9 transitional basis1 would fall to a low point of 9.1%, above HSBC's CET1 hurdle rate of 7.8%.

 

On an IFRS 9 non-transitional basis, HSBC's CET1 capital ratio is projected to reach a low point of 8.2% which is above HSBC's IFRS 9 non-transitional CET1 hurdle rate of 6.6%.

 

The Bank of England applied the same stresses in the 2018 annual cyclical scenario as used in the 2017 exercise. Using the same scenario has allowed the Bank of England to isolate the impact on the stress test results of the introduction of IFRS 9 in 2018. The scenario modelled a hypothetical synchronised global downturn with growth in Hong Kong and China and other emerging market economies in which HSBC operates being particularly adversely affected. The scenario also incorporated a rise in the UK bank rate to 4% and a sharp depreciation of sterling.

 

Today's results demonstrate HSBC's continued capital strength under this severe scenario.

 

The results incorporate strategic management actions, including CRD IV restrictions, which have been accepted by the Bank of England for the purposes of this exercise. Under adverse economic circumstances, we would in practice consider a variety of management actions depending on the particular prevailing circumstances. Our intention, as evidenced by past actions, is to maintain a conservative and prudent stance on capital management.

 

The Bank of England's 2018 stress test results are available to view in full on the Bank of England's website at: https://www.bankofengland.co.uk/news.

 

 

 

 

 

HSBC's results under the annual cyclical scenario are shown below.

 

 

 

 

Minimum stressed ratio after 'strategic' management actions and before conversion of AT1

 

 

 

 

Actual

(end-2017)(j)

Minimum stressed ratio (before 'strategic' management actions or AT1 conversions)

Non-dividend 'strategic' management actions only(i)

All 'strategic' management actions including CRD IV related restrictions

Minimum stressed ratio (after the impact of 'strategic' management actions and conversion of AT1)

Hurdle rate

Actual (2018 Q3)

IFRS 9 Transitional

 

 

 

 

 

 

 

Common equity tier 1 ratio(a) (b)

14.6%

5.8%

6.4%

9.1%

9.1%

7.8%

14.3%

Tier 1 capital ratio(c)

17.4%

7.7%(g)

8.5%(g)

11.1%(g)

11.1%(g)

 

17.3%

Total capital ratio(d)

21.0%

10.0%(g)

11.0%(g)

13.6%(g)

13.6%(g)

 

20.7%

Memo: risk weighted assets (US$ billion)

872

1,118(g)

1,039(g)

1,041(g)

1,041(g)

 

863

Memo: CET1 (US$ billion)

127

65(g)

67(g)

95(g)

95(g)

 

123

Tier 1 leverage ratio(a) (e)

6.1%

3.9%

4.0%

4.6%

4.6%

3.75%

5.9%

Memo: leverage exposure (US$ billion)

2,346

2,284(h)

2,239(h)

2,241(h)

2,241(h)

 

2,448

IFRS 9 Non-transitional

 

 

 

 

 

 

 

Common equity tier 1 ratio(f)

14.5%

6.3%

6.7%

8.2%

8.2%

6.6%

14.2%

Tier 1 leverage ratio(f)

6.1%

3.5%

3.6%

4.2%

4.2%

3.34%

5.9%

 

Sources: HSBC's published accounts and STDF submissions, Bank of England analysis and calculations.

 

(a) The low points for the common equity tier 1 (CET1) ratio and leverage ratio shown in the table do not necessarily occur in the same year of the stress scenario and correspond to the year where the minimum stressed ratio is calculated after 'strategic' management actions and before AT1 conversion.

(b) The CET1 capital ratio is defined as CET1 capital expressed as a percentage of risk-weighted assets, where these are in line with CRR and the UK implementation of CRD IV via the PRA Rulebook.

(c) Tier 1 capital ratio is defined as tier 1 capital expressed as a percentage of RWAs where tier 1 capital is defined as the sum of CET1 capital and additional tier 1 capital in line with the UK implementation of CRD IV.

(d) Total capital ratio is defined as total capital expressed as a percentage of RWAs where total capital is defined as the sum of tier 1 capital and tier 2 capital in line with the UK implementation of CRD IV.

(e) The tier 1 leverage ratio is tier 1 capital expressed as a percentage of the leverage exposure measure excluding central bank reserves, in line with the PRA's Policy Statement PS21/17.

(f) The low point year on a non-transitional IFRS 9 basis may differ to the low point year on a transitional IFRS 9 basis. Non-transitional IFRS 9 hurdle rates are hypothetical. The Bank will review its method for calculating these hurdle rates in future years.

(g) Corresponds to the same year as the minimum CET1 ratio over the stress scenario after 'strategic' management actions.

(h) Corresponds to the same year as the minimum leverage ratio over the stress scenario after 'strategic' management actions.

(i) This excludes CRD IV distribution restrictions. Where a bank is subject to such restrictions all non business as usual cuts to distributions subject to CRD IV restrictions will appear in the next column - 'All 'strategic' management actions including CRD IV distribution restrictions'. This should not be interpreted as a judgement by the Bank that any or all of such cuts are conditional on such restrictions.

(j) Actuals for end-2017 are shown on the basis of 1 January 2018 in order to incorporate the implementation of IFRS 9.

 

 

 

Investor enquiries to:Richard O'Connor +44 (0) 20 7991 6590 richard.j.oconnor@hsbc.com

Mark Phin +44 (0) 20 7992 6923 mark.j.phin@hsbc.com

 

Media enquiries to:Heidi Ashley +44 (0) 20 7992 2045 heidi.ashley@hsbc.com

Ankit Patel +44 (0) 20 7991 9813 ankit.patel@hsbc.com

 

 

Footnote:

 

1HSBC's CET1 ratio on a transitional basis is calculated using the EU's regulatory transitional arrangements for IFRS 9 in article 473a of the Capital Requirements Regulation.

 

 

Note to editors:

 

HSBC Holdings plc

HSBC Holdings plc, the parent company of the HSBC Group, is headquartered in London. The Group serves customers worldwide from around 3,800 offices in 66 countries and territories in Europe, Asia, North and Latin America, and the Middle East and North Africa. With assets of US$2,603bn at 30 September 2018, HSBC is one of the world's largest banking and financial services organisations.

 

 

ends/all

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFKFDDOBDDADB
Date   Source Headline
24th Jan 20235:34 pmRNSHolding(s) in Company
20th Jan 20239:00 amRNSOutcome of audit tender process
13th Jan 20234:30 pmRNSNotice of redemption
12th Jan 20236:06 pmRNSHolding(s) in Company
10th Jan 20239:30 amRNSOverseas Regulatory Announcement - Waivers
6th Jan 20234:30 pmRNSBlock listing Interim Review
6th Jan 20239:30 amRNSOverseas Regulatory Announcement
30th Dec 202211:00 amRNSTotal Voting Rights
29th Dec 20223:30 pmRNSDirector/PDMR Shareholding
16th Dec 202210:20 amRNSSecond Price Monitoring Extn
16th Dec 202210:15 amRNSPrice Monitoring Extension
16th Dec 20229:00 amRNSPost Stabilisation Notice
30th Nov 20224:30 pmRNSTotal Voting Rights
29th Nov 20225:35 pmRNSHolding(s) in Company
29th Nov 20224:30 pmRNSDirector/PDMR Shareholding
29th Nov 202211:30 amRNSHSBC Agrees to Sell its Business in Canada to RBC
22nd Nov 20224:30 pmRNSDirector/PDMR Shareholding
17th Nov 20229:14 amRNSHolding(s) in Company
16th Nov 20222:46 pmRNSHSBC - Issuance of Subordinated Unsecured Notes
7th Nov 202210:48 amRNSPre Stabilisation Notice
3rd Nov 20225:00 pmRNSIssuance of notes due 2026 and 2028
3rd Nov 20224:25 pmRNSHolding(s) in Company
3rd Nov 20223:05 pmRNSHolding(s) in Company
2nd Nov 20224:30 pmRNSDirector/PDMR Shareholding
31st Oct 20224:30 pmRNSTotal Voting Rights
28th Oct 20224:30 pmRNSDirector/PDMR Shareholding
26th Oct 20223:25 pmRNSBase prospectus supplement
25th Oct 20227:00 amRNSHSBC Holdings - Senior Management Changes
25th Oct 20227:00 amRNSHSBC Holdings - 3Q22 Results Webcast and Conf Call
25th Oct 20227:00 amRNSHSBC Holdings PLC - 3Q22 Results
20th Oct 20226:15 pmRNSHSBC Holdings PLC - Notice of Redemption
18th Oct 20226:23 pmRNSHolding(s) in Company
13th Oct 20229:30 amRNSOverseas Regulatory Announcement - Board Meeting
5th Oct 20225:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20224:30 pmRNSDirector/PDMR Shareholding
3rd Oct 202210:00 amRNSDirector Declaration
30th Sep 20224:30 pmRNSTotal Voting Rights
30th Sep 20223:30 pmRNSHSBC Holdings - Issuance of Senior Unsecured Notes
28th Sep 20224:30 pmRNSDirector/PDMR Shareholding
28th Sep 20229:30 amRNSOverseas Regulatory Announcement- Grant of Options
23rd Sep 202211:09 amRNSHolding(s) in Company
20th Sep 20221:00 pmRNSInterim Dividend for 2022 Half Year- Exchange Rate
15th Sep 20224:45 pmRNSIssuance of Senior & Subordinated Unsecured Bonds
14th Sep 202211:30 amRNSFinal results of exchange offers
13th Sep 20225:50 pmRNSAnnounces Pricing Terms of Cash Offers for Notes
13th Sep 20229:30 amRNSInterim Dividend Exchange Rate date change
7th Sep 20228:45 amRNSHolding(s) in Company
2nd Sep 202210:00 amRNSDirector Declaration
31st Aug 20224:45 pmRNSDirector/PDMR Shareholding
31st Aug 20224:40 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.